Sionna Therapeutics, Inc. (NASDAQ:SION)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$97.4M
- Net margin
- —
Little or no net debt.
- Total debt
- $8.1M
- Cash
- $63.3M
- Debt / equity
- 0.03
Comfortably covers what is due within a year.
- Current assets
- $216.1M
- Current liabilities
- $10.8M
- Current ratio
- 20.05
Consumes cash and must keep raising it.
- Operating cash flow
- -$97.8M
- Free cash flow
- -$98.0M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 45.1M
- Share growth (1y)
- 2.3%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
SION Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 154.00 K | 152.00 K | 0.00 | 147.00 K | 0.00 |
| Gross Profit | 0.00 | -154.00 K | -152.00 K | 0.00 | -147.00 K | 0.00 |
| SG&A Expense | 10.61 M | 10.48 M | 9.87 M | 7.24 M | 6.52 M | 5.56 M |
| R&D Expense | 21.86 M | 18.96 M | 15.17 M | 16.04 M | 15.38 M | 13.67 M |
| Operating Expenses | 32.47 M | 29.45 M | 23.46 M | 23.80 M | 21.76 M | 19.66 M |
| Operating Income | -32.47 M | -29.60 M | -23.61 M | -23.80 M | -21.91 M | -19.66 M |
| Pretax Income | -29.89 M | -26.78 M | -20.44 M | -20.28 M | -18.07 M | -16.48 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -29.89 M | -26.78 M | -20.44 M | -20.28 M | -18.07 M | -16.48 M |
| EPS (Basic) | -0.66 | -0.60 | -0.46 | -0.46 | -0.41 | -0.37 |
| EPS (Diluted) | -0.66 | -0.60 | -0.46 | -0.46 | -0.41 | -0.37 |
| Shares Outstanding | 45.15 M | 44.92 M | 39.96 M | 44.46 M | 44.13 M | 44.09 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.